Critical involvement of ILK in TGFβ1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system

Ovarian Cancer Cells ◽

Human Ovarian Cancer ◽

Activator System ◽

Abstract POSTER-THER-1440: Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system

10.1158/1557-3265.ovcasymp14-poster-ther-1440 ◽

2015 ◽

Author(s):

Yilin Zhang ◽

Elden P. Swindell ◽

Patrick L. Hankins ◽

Hilary A. Kenny ◽

Thomas V. O'Halloran ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Plasminogen Activator ◽

Targeted Delivery ◽

Ovarian Cancer Cells ◽

Activator System ◽

Urokinase Plasminogen Activator System–Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-13-0204 ◽

2013 ◽

Vol 12 (12) ◽

pp. 2628-2639 ◽

Cited By ~ 19

Author(s):

Yilin Zhang ◽

Hilary A. Kenny ◽

Elden P. Swindell ◽

Anirban K. Mitra ◽

Patrick L. Hankins ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Therapy ◽

Plasminogen Activator ◽

Targeted Delivery ◽

Activator System ◽

Abstract 2885: Urokinase plasminogen activator system targeted delivery of arsenic trioxide loaded nanobins as a novel ovarian cancer therapeutic

10.1158/1538-7445.am2012-2885 ◽

2012 ◽

Author(s):

Yilin Zhang ◽

Elden P. Swindell ◽

Richard W. Ahn ◽

Anirban Mitra ◽

Andrew P. Mazar ◽

...

Keyword(s):

Ovarian Cancer ◽

Arsenic Trioxide ◽

Plasminogen Activator ◽

Targeted Delivery ◽

Activator System ◽

Transforming growth factor b1 stimulates urokinase plasminogen activator system on prostate cancer cells

The International Journal of Biological Markers ◽

10.5301/jbm.2008.2043 ◽

2003 ◽

Vol 18 (2) ◽

pp. 147-151 ◽

Cited By ~ 1

Author(s):

A. Unl ◽

R.E. Leake

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Cells ◽

Plasminogen Activator ◽

Transforming Growth Factor ◽

Prostate Cancer Cells ◽

Activator System ◽

TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system

International Journal of Cancer ◽

10.1002/ijc.1330 ◽

2001 ◽

Vol 93 (2) ◽

pp. 204-211 ◽

Cited By ~ 98

Author(s):

Volker Ellenrieder ◽

Sandra F. Hendler ◽

Claudia Ruhland ◽

Wolfgang Boeck ◽

Guido Adler ◽

...

Keyword(s):

Pancreatic Cancer ◽

Matrix Metalloproteinase ◽

Cancer Cells ◽

Plasminogen Activator ◽

Matrix Metalloproteinase 2 ◽

Pancreatic Cancer Cells ◽

Activator System ◽

Urokinase Plasminogen Activator System in Synovial Fibroblasts from Osteoarthritis Patients: Modulation by Inflammatory Mediators and Neuropeptides

Journal of Molecular Neuroscience ◽

10.1007/s12031-013-0189-z ◽

2013 ◽

Vol 52 (1) ◽

pp. 18-27 ◽

Cited By ~ 8

Author(s):

Selene Pérez-García ◽

Mar Carrión ◽

Rebeca Jimeno ◽

Ana M. Ortiz ◽

Isidoro González-Álvaro ◽

...

Keyword(s):

Plasminogen Activator ◽

Inflammatory Mediators ◽

Synovial Fibroblasts ◽

Activator System ◽

Sphingosine-1-Phosphate Regulates Glioblastoma Cell Invasiveness through the Urokinase Plasminogen Activator System and CCN1/Cyr61

Molecular Cancer Research ◽

10.1158/1541-7786.mcr-08-0061 ◽

2009 ◽

Vol 7 (1) ◽

pp. 23-32 ◽

Cited By ~ 67

Author(s):

Nicholas Young ◽

Dennis K. Pearl ◽

James R. Van Brocklyn

Keyword(s):

Plasminogen Activator ◽

Glioblastoma Cell ◽

Sphingosine 1 Phosphate ◽

Cell Invasiveness ◽

Activator System ◽

Urokinase Type Plasminogen Activator

Induction of c- fosGene Expression by Urokinase-Type Plasminogen Activator in Human Ovarian Cancer Cells

Ovarian Cancer ◽

10.1385/1-59259-071-3:597 ◽

2003 ◽

pp. 597-600

Author(s):

Inna Dumler

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Plasminogen Activator ◽

Ovarian Cancer Cells ◽

Human Ovarian Cancer ◽

Type Plasminogen Activator ◽

Urokinase Plasminogen Activator System and Hematologic Malignancies: Potential Role in Diagnosis and Therapy

Journal of Hematology & Thromboembolic Diseases ◽

10.4172/2329-8790.1000s1e101 ◽

2015 ◽

Vol s1 ◽

Author(s):

Adel Gouri Aoulia Dekaken

Keyword(s):

Plasminogen Activator ◽

Potential Role ◽

Hematologic Malignancies ◽

Diagnosis And Therapy ◽

Activator System ◽

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

Expert Opinion on Biological Therapy ◽

10.1517/14712598.1.4.683 ◽

2001 ◽

Vol 1 (4) ◽

pp. 683-691 ◽

Cited By ~ 38

Author(s):

Manfred Schmitt ◽

Viktor Magdolen ◽

Stefan Sperl ◽

Bernd Muehlenweg ◽

Nadia Harbeck

Keyword(s):

Plasminogen Activator ◽

Solid Tumours ◽

System A ◽

Activator System ◽